These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 20927685)

  • 1. Liver injury caused by drugs: an update.
    Stirnimann G; Kessebohm K; Lauterburg B
    Swiss Med Wkly; 2010; 140():w13080. PubMed ID: 20927685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Signal transduction pathways involved in drug-induced liver injury.
    Han D; Shinohara M; Ybanez MD; Saberi B; Kaplowitz N
    Handb Exp Pharmacol; 2010; (196):267-310. PubMed ID: 20020266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dissecting the molecular pathophysiology of drug-induced liver injury.
    Ye H; Nelson LJ; Gómez Del Moral M; Martínez-Naves E; Cubero FJ
    World J Gastroenterol; 2018 Apr; 24(13):1373-1385. PubMed ID: 29632419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of in vitro combination assays of mitochondrial dysfunction and apoptosis for the estimation of potential risk of idiosyncratic drug induced liver injury.
    Goda K; Takahashi T; Kobayashi A; Shoda T; Kuno H; Sugai S
    J Toxicol Sci; 2016; 41(5):605-15. PubMed ID: 27665770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of isoniazid-induced idiosyncratic liver injury: emerging role of mitochondrial stress.
    Boelsterli UA; Lee KK
    J Gastroenterol Hepatol; 2014 Apr; 29(4):678-87. PubMed ID: 24783247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting and preventing acute drug-induced liver injury: what's new in 2010?
    Liss G; Rattan S; Lewis JH
    Expert Opin Drug Metab Toxicol; 2010 Sep; 6(9):1047-61. PubMed ID: 20615079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatotoxicity mechanisms of isoniazid: A mini-review.
    Hassan HM; Guo HL; Yousef BA; Luyong Z; Zhenzhou J
    J Appl Toxicol; 2015 Dec; 35(12):1427-32. PubMed ID: 26095833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic association studies in drug-induced liver injury.
    Daly AK; Day CP
    Drug Metab Rev; 2012 Feb; 44(1):116-26. PubMed ID: 21913872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of immune reactions in drug-induced liver injury (DILI).
    Ju C; Reilly T
    Drug Metab Rev; 2012 Feb; 44(1):107-15. PubMed ID: 22235834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of drug-induced liver injury: from bedside to bench.
    Tujios S; Fontana RJ
    Nat Rev Gastroenterol Hepatol; 2011 Apr; 8(4):202-11. PubMed ID: 21386809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The primary role of hepatic metabolism in idiosyncratic drug-induced liver injury.
    Amacher DE
    Expert Opin Drug Metab Toxicol; 2012 Mar; 8(3):335-47. PubMed ID: 22288564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacogenomics in drug induced liver injury.
    Andrade RJ; Agúndez JA; Lucena MI; Martínez C; Cueto R; García-Martín E
    Curr Drug Metab; 2009 Nov; 10(9):956-70. PubMed ID: 20214588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic basis of drug-induced liver injury: present and future.
    Urban TJ; Daly AK; Aithal GP
    Semin Liver Dis; 2014 May; 34(2):123-33. PubMed ID: 24879978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-induced liver injury: insights from genetic studies.
    Andrade RJ; Robles M; Ulzurrun E; Lucena MI
    Pharmacogenomics; 2009 Sep; 10(9):1467-87. PubMed ID: 19761370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug-induced liver injury: Advances in mechanistic understanding that will inform risk management.
    Mosedale M; Watkins PB
    Clin Pharmacol Ther; 2017 Apr; 101(4):469-480. PubMed ID: 27861792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unraveling cellular pathways contributing to drug-induced liver injury by dynamical modeling.
    Kuijper IA; Yang H; Van De Water B; Beltman JB
    Expert Opin Drug Metab Toxicol; 2017 Jan; 13(1):5-17. PubMed ID: 27609146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utilization of causal reasoning of hepatic gene expression in rats to identify molecular pathways of idiosyncratic drug-induced liver injury.
    Laifenfeld D; Qiu L; Swiss R; Park J; Macoritto M; Will Y; Younis HS; Lawton M
    Toxicol Sci; 2014 Jan; 137(1):234-48. PubMed ID: 24136188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence-based selection of training compounds for use in the mechanism-based integrated prediction of drug-induced liver injury in man.
    Dragovic S; Vermeulen NP; Gerets HH; Hewitt PG; Ingelman-Sundberg M; Park BK; Juhila S; Snoeys J; Weaver RJ
    Arch Toxicol; 2016 Dec; 90(12):2979-3003. PubMed ID: 27659300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reactive Metabolites: Current and Emerging Risk and Hazard Assessments.
    Thompson RA; Isin EM; Ogese MO; Mettetal JT; Williams DP
    Chem Res Toxicol; 2016 Apr; 29(4):505-33. PubMed ID: 26735163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Idiosyncratic drug-induced liver injury: an update on the 2007 overview.
    Hussaini SH; Farrington EA
    Expert Opin Drug Saf; 2014 Jan; 13(1):67-81. PubMed ID: 24073714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.